TORNTPHARM Torrent Pharmaceuticals Ltd
Healthcare
LTP
4,750
CHG · %
+40 (+0.85%)
VOL · TODAY
3.59L
PREV CLOSE
4,710
Today's range4,699.1 · 4,789.5
4,750
52-week range3,532.6 · 5,250
4,750
Loading candles…
Torrent Pharmaceuticals Ltd is the flagship company of the Torrent Group, engaged in the research, development, manufacturing, and marketing of generic pharmaceutical formulations. Its operations cover specialty-driven pharmaceutical markets with a focus on chronic and sub-chronic therapies, which account for approximately 76% of its revenues in India. The company operates in the pharmaceuticals, power, and city gas distribution industries and offers products including cardiovascular drugs, central nervous system drugs, gastrointestinal drugs, and vitamins, minerals, and nutrients. Torrent Pharmaceuticals has a global presence with operations in India, Brazil, and Germany. It runs eight manufacturing facilities, five of which are approved by the USFDA, and maintains a dedicated R&D center staffed by over 750 scientists.
This page is a live market overview for TORRENT PHARMACEUTICALS L (TORNTPHARM) on the NSE. As a listed security, TORRENT PHARMACEUTICALS L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for TORNTPHARM before placing trades on tick2trade.
As of the latest feed, TORNTPHARM last traded at ₹4,750 on NSE, up ₹40 (0.85%) from the previous close of ₹4,710. Today's session range is ₹4,699.1 – ₹4,789.5, against a 52-week band of ₹3,532.6 – ₹5,250. Traded volume today stands at 3.59L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for TORNTPHARM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether TORNTPHARM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for TORRENT PHARMACEUTICALS L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in TORNTPHARM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated TORNTPHARM option chain page linked from this overview.
// similar in healthcare326 total